Respiratory Health

We collaborate with healthcare professionals, patients, and caregivers to better understand their needs and challenges, driving us to create solutions that truly make a difference. 

Teva is deeply committed to improving respiratory health, focusing mainly on asthma, which significantly impacts millions of lives worldwide, and we aim to address this burden through innovation, research, and patient-centric care. 

Asthma is one of the most common chronic respiratory conditions globally. It affects over 260 million people, causing significant health challenges, particularly in children and young adults. 01 Asthma can lead to frequent hospital visits, missed school or workdays, and a reduced quality of life. Managing this condition requires ongoing treatment and monitoring, making it a critical focus area for Teva. 

Teva brings decades of expertise in respiratory care. Our commitment is reflected in our extensive portfolio of both innovative and generic medications. We invest in research and development to continuously improve our offerings, ensuring that patients have access to the most effective treatments available across all our respiratory therapeutic areas.

Living with Asthma: Stories by patients, for patients

Through platforms like Life Effects, we provide valuable resources and personal stories from those living with respiratory conditions including asthma, COPD, and cystic fibrosis.  

These stories offer insights, encouragement, and practical advice for dealing with asthma and other respiratory conditions, helping people feel less isolated in their experiences.  

Explore their stories here. 

Beyond our pharmaceutical expertise, we recognize the importance of supporting patients and caregivers in their journey. Whether you're a patient, caregiver, or prospective employee, we invite you to be part of our efforts to improve respiratory health worldwide. 

NPS-ALL-NP-01528 APRIL 2025

  1. Back to contents.

    https://www.who.int/news-room/fact-sheets/detail/asthma